Category Archives: Pharmaceuticals & Biotech
The Key Fibromyalgia Companies in the market include – Tonix Pharmaceutical, UCB Biopharma SRL, GlaxoSmithKline, UCB Pharma, Pierre Fabre Medicament, UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, AstraZeneca, RiboCor, Inc., Bial – Portela C S.A, and others. … Continue reading
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Celiac Disease pipeline constitutes 25+ key companies continuously working towards developing 30+ Celiac Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading
CinDome Pharma “CIN-102” Market size expansion of Several Folds by 2034
Explore DelveInsight’s comprehensive report on CIN-102 (CinDome Pharma), offering market insights, sales forecast, and analysis through 2034. [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on CIN-102 (CinDome Pharma) providing … Continue reading
TRYPTYR by Aerie Pharmaceuticals expected to drive market size of Dry Eye Disease
Explore DelveInsight’s comprehensive report on TRYPTYR (Aerie Pharmaceuticals), offering market insights, sales forecasts, and analysis of the drug landscape through 2034. [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on … Continue reading
Why Mental Clarity and Flow State Are Becoming a Priority for High-Achieving Professionals
In a world where thinking is the primary currency, mental clarity is no longer a “nice to have.” For high-achieving professionals, founders, academics, and adult students, cognitive performance defines outcomes. Yet an increasing number of driven individuals report the same … Continue reading
Donanemab by Eli Lilly and Company expected to drive market size of Alzheimer’s Disease
Explore the comprehensive Donanemab market report by a leading healthcare research firm, offering detailed insights, sales forecasts, and market analysis up to 2034. [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth … Continue reading
The Key Spinal Cord Injury Companies in the market include – Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others. DelveInsight’s “Spinal … Continue reading
DelveInsight’s, “Follicular Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading
DelveInsight’s “Fabry Disease Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in the Fabry Disease pipeline landscape. It covers the Fabry Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading
